BioSpace News Archive

Polydex Pharmaceuticals Limited announces 3rd quarter financial results.

Danaher Corporation announced the preliminary results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation owned by Danaher.

ChromaDex Corp. (NASDAQ:CDXC) announced today that Nutritional Outlook®, a leading publication for the nutraceuticals industry, recently awarded ChromaDex the 2019 “Best of Industry Award,” in the “Ingredient Supplier” category, for Niagen® (nicotinamide riboside).

Avivagen Inc. (TSXV:VIV) (“Avivagen”) has entered into a memorandum of understanding with INPHILCO, Inc. setting out the terms under which the parties propose that INPHILCO will become a new, key distribution partner for OxC-betaTM Livestock in the rapidly growing Philippines market.

Eli Lilly and Company (NYSE: LLY) has announced a global commercialization agreement to integrate DexCom, Inc. (NASDAQ: DXCM) products into Lilly’s personalized diabetes management system, currently in development to advance the treatment of diabetes

Cigna’s policy covers the use of all FDA-cleared implants placed across the SI joint and intended to promote bone fusion

eSolutions, a leading healthcare technology company, is proud to announce that Joe Bell, General Manager, Clearinghouse, has been elected as a member of the Workgroup for Electronic Data Interchange’s (WEDI) Board of Directors for 2020.

Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, announced today that the first patient has been randomized in Europe into its pivotal Phase 3 InnovAATe clinical trial evaluating the safety and efficacy of the Company’s proprietary inhaled Alpha-1 Antitrypsin (AAT) therapy for the treatment of Alpha-1 Antitrypsin Deficiency (AATD).

Akcea Therapeutics Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., today announced the appointments of Lynne Parshall, J.D., as chair of the Akcea Board of Directors and Barbara Yanni as a new member of the board. Both positions are effective immediately.

Applied Therapeutics Inc. (Nasdaq:APLT), announced today that Shoshana Shendelman, Ph.D., Founder, Chief Executive Officer and Chair of the Board, will ring the Nasdaq Closing Bell on Tuesday, December 17, 2019, at 4:00 p.m. ET.